130 related articles for article (PubMed ID: 30149702)
1. Mapping the Orthosteric Binding Site of the Human 5-HT
Jack T; Leuenberger M; Ruepp MD; Vernekar SKV; Thompson AJ; Braga-Lagache S; Heller M; Lochner M
ACS Chem Neurosci; 2019 Jan; 10(1):438-450. PubMed ID: 30149702
[TBL] [Abstract][Full Text] [Related]
2. The binding orientations of structurally-related ligands can differ; A cautionary note.
Ruepp MD; Wei H; Leuenberger M; Lochner M; Thompson AJ
Neuropharmacology; 2017 Jun; 119():48-61. PubMed ID: 28137449
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Pharmacological Evaluation of [
Mu L; Müller Herde A; Rüefli PM; Sladojevich F; Milicevic Sephton S; Krämer SD; Thompson AJ; Schibli R; Ametamey SM; Lochner M
ACS Chem Neurosci; 2016 Nov; 7(11):1552-1564. PubMed ID: 27571447
[TBL] [Abstract][Full Text] [Related]
4. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
Lochner M; Thompson AJ
Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
[TBL] [Abstract][Full Text] [Related]
5. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
6. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.
Yan D; White MM
Mol Pharmacol; 2005 Aug; 68(2):365-71. PubMed ID: 15914697
[TBL] [Abstract][Full Text] [Related]
7. Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.
Vernekar SK; Hallaq HY; Clarkson G; Thompson AJ; Silvestri L; Lummis SC; Lochner M
J Med Chem; 2010 Mar; 53(5):2324-8. PubMed ID: 20146481
[TBL] [Abstract][Full Text] [Related]
8. Palonosetron-5-HT
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
[TBL] [Abstract][Full Text] [Related]
9. The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.
Zarkadas E; Zhang H; Cai W; Effantin G; Perot J; Neyton J; Chipot C; Schoehn G; Dehez F; Nury H
Structure; 2020 Oct; 28(10):1131-1140.e4. PubMed ID: 32726573
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of ligand recognition in 5-HT3 receptors.
Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.
Duffy NH; Lester HA; Dougherty DA
ACS Chem Biol; 2012 Oct; 7(10):1738-45. PubMed ID: 22873819
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM
Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804
[TBL] [Abstract][Full Text] [Related]
13. "Methylene Bridge" to 5-HT
Abdelkhalek AS; Alley GS; Alwassil OI; Khatri S; Mosier PD; Nyce HL; White MM; Schulte MK; Dukat M
ACS Chem Neurosci; 2019 Mar; 10(3):1380-1389. PubMed ID: 30375852
[TBL] [Abstract][Full Text] [Related]
14. Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.
Thompson AJ; Chau PL; Chan SL; Lummis SC
Biophys J; 2006 Mar; 90(6):1979-91. PubMed ID: 16387779
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of photoaffinity probes that target the 5-HT3 receptor.
Jack T; Ruepp MD; Thompson AJ; Mühlemann O; Lochner M
Chimia (Aarau); 2014; 68(4):239-42. PubMed ID: 24983606
[TBL] [Abstract][Full Text] [Related]
16. Discriminating between 5-HT₃A and 5-HT₃AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Jun; 169(4):736-47. PubMed ID: 23489111
[TBL] [Abstract][Full Text] [Related]
17. Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
Del Cadia M; De Rienzo F; Weston DA; Thompson AJ; Menziani MC; Lummis SC
Bioorg Med Chem; 2013 Dec; 21(23):7523-8. PubMed ID: 24128813
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
[TBL] [Abstract][Full Text] [Related]
19. Interactions of granisetron with an agonist-free 5-HT3A receptor model.
Joshi PR; Suryanarayanan A; Hazai E; Schulte MK; Maksay G; Bikádi Z
Biochemistry; 2006 Jan; 45(4):1099-105. PubMed ID: 16430206
[TBL] [Abstract][Full Text] [Related]
20. Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.
Hu XQ
Br J Pharmacol; 2015 Jan; 172(1):93-105. PubMed ID: 25176133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
